These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 17702031

  • 1. Riluzole in Huntington's disease: a 3-year, randomized controlled study.
    Landwehrmeyer GB, Dubois B, de Yébenes JG, Kremer B, Gaus W, Kraus PH, Przuntek H, Dib M, Doble A, Fischer W, Ludolph AC, European Huntington's Disease Initiative Study Group.
    Ann Neurol; 2007 Sep; 62(3):262-72. PubMed ID: 17702031
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A controlled trial of remacemide hydrochloride in Huntington's disease.
    Kieburtz K, Feigin A, McDermott M, Como P, Abwender D, Zimmerman C, Hickey C, Orme C, Claude K, Sotack J, Greenamyre JT, Dunn C, Shoulson I.
    Mov Disord; 1996 May; 11(3):273-7. PubMed ID: 8723144
    [Abstract] [Full Text] [Related]

  • 4. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Meininger V, Asselain B, Guillet P, Leigh PN, Ludolph A, Lacomblez L, Robberecht W, Pentoxifylline European Group.
    Neurology; 2006 Jan 10; 66(1):88-92. PubMed ID: 16401852
    [Abstract] [Full Text] [Related]

  • 5. Riluzole in Huntington's disease (HD): an open label study with one year follow up.
    Seppi K, Mueller J, Bodner T, Brandauer E, Benke T, Weirich-Schwaiger H, Poewe W, Wenning GK.
    J Neurol; 2001 Oct 10; 248(10):866-9. PubMed ID: 11697523
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A controlled trial of idebenone in Huntington's disease.
    Ranen NG, Peyser CE, Coyle JT, Bylsma FW, Sherr M, Day L, Folstein MF, Brandt J, Ross CA, Folstein SE.
    Mov Disord; 1996 Sep 10; 11(5):549-54. PubMed ID: 8866496
    [Abstract] [Full Text] [Related]

  • 9. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial.
    de Yebenes JG, Landwehrmeyer B, Squitieri F, Reilmann R, Rosser A, Barker RA, Saft C, Magnet MK, Sword A, Rembratt A, Tedroff J, MermaiHD study investigators.
    Lancet Neurol; 2011 Dec 10; 10(12):1049-57. PubMed ID: 22071279
    [Abstract] [Full Text] [Related]

  • 10. A pilot study using nabilone for symptomatic treatment in Huntington's disease.
    Curtis A, Mitchell I, Patel S, Ives N, Rickards H.
    Mov Disord; 2009 Nov 15; 24(15):2254-9. PubMed ID: 19845035
    [Abstract] [Full Text] [Related]

  • 11. [Tolerance of riluzole in a phase IIIb clinical trial].
    Lacomblez L, Dib M, Doppler V, Faudet A, Robin V, Salachas F, Bensimon G, Meininger V.
    Therapie; 2002 Nov 15; 57(1):65-71. PubMed ID: 12090150
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
    Zoing MC, Burke D, Pamphlett R, Kiernan MC.
    J Clin Neurosci; 2006 Jan 15; 13(1):78-83. PubMed ID: 16410201
    [Abstract] [Full Text] [Related]

  • 14. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
    de Tommaso M, Specchio N, Sciruicchio V, Difruscolo O, Specchio LM.
    Mov Disord; 2004 Dec 15; 19(12):1516-8. PubMed ID: 15390067
    [Abstract] [Full Text] [Related]

  • 15. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I, Camu W, Hillaire-Buys D.
    Therapie; 2000 Dec 15; 55(2):303-12. PubMed ID: 10967703
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov 15; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 17. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G, Romano S, Visconti A, Cannoni S, Spadaro M, Frontali M, Pontieri FE, Vanacore N, Salvetti M.
    Neurology; 2010 Mar 09; 74(10):839-45. PubMed ID: 20211908
    [Abstract] [Full Text] [Related]

  • 18. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH, Klasser M, Reichmann H.
    Fortschr Neurol Psychiatr; 2008 Oct 09; 76(10):594-9. PubMed ID: 18833504
    [Abstract] [Full Text] [Related]

  • 19. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D, Chevret S, Quera-Salva MA, Laforêt P, Lofaso F, Verschueren A, Pouget J, Eymard B, Annane D.
    Clin Ther; 2009 Aug 09; 31(8):1765-73. PubMed ID: 19808135
    [Abstract] [Full Text] [Related]

  • 20. A phase 1 trial of riluzole in spinal muscular atrophy.
    Russman BS, Iannaccone ST, Samaha FJ.
    Arch Neurol; 2003 Nov 09; 60(11):1601-3. PubMed ID: 14623733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.